Global Elapegademase-lvlr Drugs Market Status, Trends and COVID-19 Impact Report 2021
In the past few years, the Elapegademase-lvlr Drugs market experienced a huge change
under the influence of COVID-19, the global market size of Elapegademase-lvlr Drugs
reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016
with a CAGR of XXX from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases
have exceeded 200 million, and the global epidemic has been basically under control,
therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The
World Bank predicts that the global economic output is expected to expand 4 percent in
2021 while 3.8 percent in 2022. According to our research on Elapegademase-lvlr Drugs
market and global economic environment, we forecast that the global market size of
Elapegademase-lvlr Drugs will reach (2026 Market size XXXX) million $ in 2026 with a
CAGR of % from 2021-2026.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Elapegademase-lvlr Drugs Market Status, Trends and
COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global
Elapegademase-lvlr Drugs market , This Report covers the manufacturer data, including:
sales volume, price, revenue, gross margin, business distribution etc., these data help the
consumer know about the competitors better. This report also covers all the regions and
countries of the world, which shows the regional development status, including market size,
volume and value, as well as price data. Besides, the report also covers segment data,
including: type wise, industry wise, channel wise etc. all the data period is from 2015-
2021E, this report also provide forecast data from 2021-2026.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Leadiant Biosciences
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Pre-filled
Vial
Application Segmentation
Hospital
Pharmacy
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2021-2026)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
under the influence of COVID-19, the global market size of Elapegademase-lvlr Drugs
reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016
with a CAGR of XXX from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases
have exceeded 200 million, and the global epidemic has been basically under control,
therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The
World Bank predicts that the global economic output is expected to expand 4 percent in
2021 while 3.8 percent in 2022. According to our research on Elapegademase-lvlr Drugs
market and global economic environment, we forecast that the global market size of
Elapegademase-lvlr Drugs will reach (2026 Market size XXXX) million $ in 2026 with a
CAGR of % from 2021-2026.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Elapegademase-lvlr Drugs Market Status, Trends and
COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global
Elapegademase-lvlr Drugs market , This Report covers the manufacturer data, including:
sales volume, price, revenue, gross margin, business distribution etc., these data help the
consumer know about the competitors better. This report also covers all the regions and
countries of the world, which shows the regional development status, including market size,
volume and value, as well as price data. Besides, the report also covers segment data,
including: type wise, industry wise, channel wise etc. all the data period is from 2015-
2021E, this report also provide forecast data from 2021-2026.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
Leadiant Biosciences
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Pre-filled
Vial
Application Segmentation
Hospital
Pharmacy
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2021-2026)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
SECTION 1 ELAPEGADEMASE-LVLR DRUGS MARKET OVERVIEW
1.1 Elapegademase-lvlr Drugs Market Scope
1.2 COVID-19 Impact on Elapegademase-lvlr Drugs Market
1.3 Global Elapegademase-lvlr Drugs Market Status and Forecast Overview
1.3.1 Global Elapegademase-lvlr Drugs Market Status 2016-2021
1.3.2 Global Elapegademase-lvlr Drugs Market Forecast 2021-2026
SECTION 2 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET MANUFACTURER SHARE
2.1 Global Manufacturer Elapegademase-lvlr Drugs Sales Volume
2.2 Global Manufacturer Elapegademase-lvlr Drugs Business Revenue
SECTION 3 MANUFACTURER ELAPEGADEMASE-LVLR DRUGS BUSINESS INTRODUCTION
3.1 Leadiant Biosciences Elapegademase-lvlr Drugs Business Introduction
3.1.1 Leadiant Biosciences Elapegademase-lvlr Drugs Sales Volume, Price, Revenue and
Gross margin 2016-2021
3.1.2 Leadiant Biosciences Elapegademase-lvlr Drugs Business Distribution by Region
3.1.3 Leadiant Biosciences Interview Record
3.1.4 Leadiant Biosciences Elapegademase-lvlr Drugs Business Profile
3.1.5 Leadiant Biosciences Elapegademase-lvlr Drugs Product Specification
3.2.3 Interview Record
3.3 Manufacturer three Elapegademase-lvlr Drugs Business Introduction
3.3.1 Manufacturer three Elapegademase-lvlr Drugs Sales Volume, Price, Revenue and Gross
margin 2016-2021
3.3.2 Manufacturer three Elapegademase-lvlr Drugs Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Elapegademase-lvlr Drugs Business Overview
3.3.5 Manufacturer three Elapegademase-lvlr Drugs Product Specification
…
SECTION 4 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY REGION)
4.1 North America Country
4.1.1 United States Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.1.2 Canada Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.1.3 Mexico Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.2.2 Argentina Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.2 Japan Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.3 India Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.4 Korea Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.2 UK Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.3 France Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.4 Spain Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.5 Italy Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.5.2 Middle East Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.6 Global Elapegademase-lvlr Drugs Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Elapegademase-lvlr Drugs Market Segmentation (By Region) Analysis
SECTION 5 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY PRODUCT TYPE)
5.1 Product Introduction by Type
5.1.1 Pre-filled Product Introduction
5.1.2 Vial Product Introduction
5.2 Global Elapegademase-lvlr Drugs Sales Volume by Vial016-2021
5.3 Global Elapegademase-lvlr Drugs Market Size by Vial016-2021
5.4 Different Elapegademase-lvlr Drugs Product Type Price 2016-2021
5.5 Global Elapegademase-lvlr Drugs Market Segmentation (By Type) Analysis
SECTION 6 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY APPLICATION)
6.1 Global Elapegademase-lvlr Drugs Sales Volume by Application 2016-2021
6.2 Global Elapegademase-lvlr Drugs Market Size by Application 2016-2021
6.2 Elapegademase-lvlr Drugs Price in Different Application Field 2016-2021
6.3 Global Elapegademase-lvlr Drugs Market Segmentation (By Application) Analysis
SECTION 7 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY CHANNEL)
7.1 Global Elapegademase-lvlr Drugs Market Segmentation (By Channel) Sales Volume and
Share 2016-2021
7.2 Global Elapegademase-lvlr Drugs Market Segmentation (By Channel) Analysis
SECTION 8 ELAPEGADEMASE-LVLR DRUGS MARKET FORECAST 2021-2026
8.1 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Region)
8.2 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Type)
8.3 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Application)
8.4 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Elapegademase-lvlr Drugs Price Forecast
SECTION 9 ELAPEGADEMASE-LVLR DRUGS APPLICATION AND CLIENT ANALYSIS
9.1 Hospital Customers
9.2 Pharmacy Customers
SECTION 10 ELAPEGADEMASE-LVLR DRUGS MANUFACTURING COST OF ANALYSIS
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview
SECTION 11 CONCLUSION
SECTION 12 METHODOLOGY AND DATA SOURCE
1.1 Elapegademase-lvlr Drugs Market Scope
1.2 COVID-19 Impact on Elapegademase-lvlr Drugs Market
1.3 Global Elapegademase-lvlr Drugs Market Status and Forecast Overview
1.3.1 Global Elapegademase-lvlr Drugs Market Status 2016-2021
1.3.2 Global Elapegademase-lvlr Drugs Market Forecast 2021-2026
SECTION 2 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET MANUFACTURER SHARE
2.1 Global Manufacturer Elapegademase-lvlr Drugs Sales Volume
2.2 Global Manufacturer Elapegademase-lvlr Drugs Business Revenue
SECTION 3 MANUFACTURER ELAPEGADEMASE-LVLR DRUGS BUSINESS INTRODUCTION
3.1 Leadiant Biosciences Elapegademase-lvlr Drugs Business Introduction
3.1.1 Leadiant Biosciences Elapegademase-lvlr Drugs Sales Volume, Price, Revenue and
Gross margin 2016-2021
3.1.2 Leadiant Biosciences Elapegademase-lvlr Drugs Business Distribution by Region
3.1.3 Leadiant Biosciences Interview Record
3.1.4 Leadiant Biosciences Elapegademase-lvlr Drugs Business Profile
3.1.5 Leadiant Biosciences Elapegademase-lvlr Drugs Product Specification
3.2.3 Interview Record
3.3 Manufacturer three Elapegademase-lvlr Drugs Business Introduction
3.3.1 Manufacturer three Elapegademase-lvlr Drugs Sales Volume, Price, Revenue and Gross
margin 2016-2021
3.3.2 Manufacturer three Elapegademase-lvlr Drugs Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Elapegademase-lvlr Drugs Business Overview
3.3.5 Manufacturer three Elapegademase-lvlr Drugs Product Specification
…
SECTION 4 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY REGION)
4.1 North America Country
4.1.1 United States Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.1.2 Canada Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.1.3 Mexico Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.2.2 Argentina Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.2 Japan Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.3 India Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.4 Korea Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.2 UK Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.3 France Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.4 Spain Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.4.5 Italy Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.5.2 Middle East Elapegademase-lvlr Drugs Market Size and Price Analysis 2016-2021
4.6 Global Elapegademase-lvlr Drugs Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Elapegademase-lvlr Drugs Market Segmentation (By Region) Analysis
SECTION 5 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY PRODUCT TYPE)
5.1 Product Introduction by Type
5.1.1 Pre-filled Product Introduction
5.1.2 Vial Product Introduction
5.2 Global Elapegademase-lvlr Drugs Sales Volume by Vial016-2021
5.3 Global Elapegademase-lvlr Drugs Market Size by Vial016-2021
5.4 Different Elapegademase-lvlr Drugs Product Type Price 2016-2021
5.5 Global Elapegademase-lvlr Drugs Market Segmentation (By Type) Analysis
SECTION 6 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY APPLICATION)
6.1 Global Elapegademase-lvlr Drugs Sales Volume by Application 2016-2021
6.2 Global Elapegademase-lvlr Drugs Market Size by Application 2016-2021
6.2 Elapegademase-lvlr Drugs Price in Different Application Field 2016-2021
6.3 Global Elapegademase-lvlr Drugs Market Segmentation (By Application) Analysis
SECTION 7 GLOBAL ELAPEGADEMASE-LVLR DRUGS MARKET SEGMENTATION (BY CHANNEL)
7.1 Global Elapegademase-lvlr Drugs Market Segmentation (By Channel) Sales Volume and
Share 2016-2021
7.2 Global Elapegademase-lvlr Drugs Market Segmentation (By Channel) Analysis
SECTION 8 ELAPEGADEMASE-LVLR DRUGS MARKET FORECAST 2021-2026
8.1 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Region)
8.2 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Type)
8.3 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Application)
8.4 Elapegademase-lvlr Drugs Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Elapegademase-lvlr Drugs Price Forecast
SECTION 9 ELAPEGADEMASE-LVLR DRUGS APPLICATION AND CLIENT ANALYSIS
9.1 Hospital Customers
9.2 Pharmacy Customers
SECTION 10 ELAPEGADEMASE-LVLR DRUGS MANUFACTURING COST OF ANALYSIS
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview
SECTION 11 CONCLUSION
SECTION 12 METHODOLOGY AND DATA SOURCE
CHART AND FIGURE
Figure Elapegademase-lvlr Drugs Product Picture
Chart Global Elapegademase-lvlr Drugs Market Size (with or without the impact of COVID-
19)
Chart Global Elapegademase-lvlr Drugs Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Elapegademase-lvlr Drugs Market Size (Million $) and Growth Rate 2016-2021
Chart Global Elapegademase-lvlr Drugs Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Elapegademase-lvlr Drugs Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Sales Volume Share
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Business Revenue
(Million USD)
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Business Revenue Share
Chart Leadiant Biosciences Elapegademase-lvlr Drugs Sales Volume, Price, Revenue and
Gross margin 2016-2021
Chart Leadiant Biosciences Elapegademase-lvlr Drugs Business Distribution
Chart Leadiant Biosciences Interview Record (Partly)
Chart Leadiant Biosciences Elapegademase-lvlr Drugs Business Profile
Table Leadiant Biosciences Elapegademase-lvlr Drugs Product Specification
…
…
Chart United States Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size
(Million $) 2016-2021
Chart United States Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Canada Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Canada Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Mexico Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Mexico Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Brazil Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Brazil Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Argentina Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Argentina Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart China Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Figure Elapegademase-lvlr Drugs Product Picture
Chart Global Elapegademase-lvlr Drugs Market Size (with or without the impact of COVID-
19)
Chart Global Elapegademase-lvlr Drugs Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Elapegademase-lvlr Drugs Market Size (Million $) and Growth Rate 2016-2021
Chart Global Elapegademase-lvlr Drugs Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Elapegademase-lvlr Drugs Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Sales Volume Share
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Business Revenue
(Million USD)
Chart 2016-2021 Global Manufacturer Elapegademase-lvlr Drugs Business Revenue Share
Chart Leadiant Biosciences Elapegademase-lvlr Drugs Sales Volume, Price, Revenue and
Gross margin 2016-2021
Chart Leadiant Biosciences Elapegademase-lvlr Drugs Business Distribution
Chart Leadiant Biosciences Interview Record (Partly)
Chart Leadiant Biosciences Elapegademase-lvlr Drugs Business Profile
Table Leadiant Biosciences Elapegademase-lvlr Drugs Product Specification
…
…
Chart United States Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size
(Million $) 2016-2021
Chart United States Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Canada Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Canada Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Mexico Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Mexico Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Brazil Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Brazil Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart Argentina Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
Chart Argentina Elapegademase-lvlr Drugs Sales Price (USD/Unit) 2016-2021
Chart China Elapegademase-lvlr Drugs Sales Volume (Units) and Market Size (Million $)
2016-2021
